Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Can-Fite BioPharma - Can-Fite Announces Positive Results From Its Phase II Trial Treating Keratoconjunctivitis Sicca Dry Eye Syndrome With CF101
Concordia Pharmaceuticals - Concordia Pharmaceuticals Reports Encouraging Clinical Data in Patients with K-Ras Mutations Treated with First-in-Class Ras Antagonist, Salirasib
Inflammatory Bowel Disease - InDex Pharmaceuticals AB Engages PharmaVentures to Facilitate the Licensing of Kappaproct(R) After Phase IIa Trial Achieves Clinical Endpoints Early
Koronis Pharmaceuticals, Inc. - Koronis Pharmaceuticals’ Scientific Advisory Board Confirms KP-1461 Clinical Drug Activity, HIV Ablation
Acute Lymphoblastic Leukemia - Research from H. Sakamaki and colleagues has provided new data on acute lymphoblastic leukemia
Brain Metastasis - Reports outline brain metastasis study results from L. Ridolfi et al
Cancer - Studies from M.R. Cooper et al further understanding of cancer
Carcinoma - Recent findings from Carl Gustav Carus University highlight research in carcinoma
Chronic Myeloid Leukemia - Data from F. Castagnetti et al provide new insights into chronic myeloid leukemia
Colon Cancer - Study findings from S.Y. Kim et al broaden understanding of colon cancer
Depression - Research from A.J. Cutler and co-authors in the area of depression published
Dialysis - Study findings on dialysis are outlined in reports from A.L.M. Defrancisco and colleagues
Esophageal Cancer - Reports outline esophageal cancer study findings from V. Chiarionsileni and colleagues
Esophageal Cancer - Research from University of Queensland in esophageal cancer provides new insights
Gene Therapy - Researchers at Okayama University target gene therapy
Immunization - Reports by T. Town and co-researchers describe recent advances in immunization
Life Sciences - Study results from J. Leyden and colleagues in the area of life sciences published
Multiple Sclerosis - Studies from B. Bielekova and colleagues reveal new findings on multiple sclerosis
Oligodendroglioma - Recent findings in oligodendroglioma described by researchers from Cleveland Clinic
Pancreatic Cancer - Studies in the area of pancreatic cancer reported from S.Y. Yi and co-researchers
Pharmacokinetics - Reports from Ohio State University advance knowledge in pharmacokinetics
Pharmacokinetics - Research from P. Perrotti and co-researchers yields new findings on pharmacokinetics
Pharmacological - Researchers at Medical University of Innsbruck target pharmacological
Soft Tissue Sarcoma - Research from M.S. Brady and co-researchers in the area of soft tissue sarcoma published
Systemic Sclerosis - New findings reported from University of California describe advances in systemic sclerosis
Gastric Cancer Therapy - Reports outline gastric cancer therapy research from National Cancer Center Hospital East, Department of Surgical Oncology
Non-Hodgkin Lymphoma Therapy - Data from University of Arizona, Arizona Cancer Center advance knowledge in non-hodgkin lymphoma therapy
A.P. Pharma, Inc. - A.P. Pharma Submits New Drug Application for APF530 in Chemotherapy-Induced Nausea and Vomiting
Antares Pharma, Inc. - Antares Pharma and Population Council Announce Preliminary Positive Phase 2 Trial Results
Aradigm Corporation - Aradigm Presents Phase 2 Data on Inhaled Liposomal Ciprofloxacin in Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis at 2009 International Conference of the American Thoracic Society
Ardea Biosciences, Inc. - Ardea Biosciences to Present Preclinical and Phase 1 Data on its Lead Gout Product Candidate, RDEA594, at the Annual European Congress of Rheumatology
Biopharmaceuticals - DOR BioPharma Reports 1st Quarter 2009 Financial Results and Reviews Recent Accomplishments
Biopharmaceuticals - Keryx Biopharmaceuticals Announces Appointment of Ron Bentsur as Chief Executive Officer
Biotechnology Business - Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS)
Breast Cancer - Mayo Clinic Researchers Say Triple Drug Combination is Promising Option to Treat Metastatic HER2+ Breast Cancer
Drug Resistance - Novexel to Present Four Posters at the 19th European Congress of Clinical Microbiology and Infectious Diseases in Helsinki
Drug Resistance - Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Sarcoma and Osteosarcoma: Phase I/II and Phase II Studies, ASCO 2009
Drug Resistance - Trius Presents New Data on Torezolid Antibiotic for Treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections
Endometriosis - Neurocrine Announces Full Year Results from 603 Study (Petal Study) of Elagolix for Treatment of Endometriosis Pain
EntreMed, Inc. - EntreMed ENMD-2076 Phase 1 Data to Be Presented at ASCO Annual Meeting
Enzyme Research - Cylene to Announce New Data on Its First-in-Class Oral CK2 Inhibitor Against Cancer at BIO Conference
Exelixis, Inc. - Exelixis Announces June 1 Webcast of Its ASCO Investor and Analyst Briefing
Genta Incorporated - Independent Data Monitoring Board Recommends Continuation to Completion of Genta’s Phase 3 Trial of Genasense® in Advanced Melanoma
Head and Neck Cancer - BioVex to Report Phase I/II Clinical Trial Results for the Front Line Treatment of Head and Neck Cancer With OncoVEX GM-CSF at the 2009 American Society of Clinical Oncology Meeting
HIV/AIDS - Chuck Panozzo, Founder of Rock Band Styx, Joins GeoVax Labs, Inc. as an Advocate for Its HIV/AIDS Vaccine
LifeCycle Pharma A/S - LifeCycle Pharma Achieved Strong Progress in its Pipeline
Liver Cancer - Nexavar Approved in Japan for the Treatment of Advanced Liver Cancer
Medivation, Inc. - Medivation Announces Upcoming Presentation of New MDV3100 Data in Patients With Advanced Prostate Cancer at 45th American Society of Clinical Oncology Annual Meeting
Melanoma - BioVex To Announce Updated Survival Data From a Phase II Clinical Study of OncoVEX GM-CSF in Metastatic Melanoma at the 2009 American Society of Clinical Oncology Meeting
OSI Pharmaceuticals, Inc. - OSI Pharmaceuticals Provides Update on OSI-906 Data Being Presented on May 30th at the Upcoming Annual Meeting of the American Society of Clinical Oncology ASCO
Pediatrics - PARI Pharma's Nebulized DSCG Shows Results Similar to Inhaled Steroids in Asthma Studies Presented at ATS
Pfizer - Pfizer to Present New Clinical Data Highlighting Customized Treatment Approaches for Difficult-To-Treat Cancers
Plexxikon Inc. - Key Data Related to Plexxikon’s Lead Oncology Program PLX4032 to be Presented at ASCO 2009 Annual Meeting
Rexahn Pharmaceuticals, Inc. - Rexahn Achieves 50% Enrollment Milestone in Serdaxin™ Phase IIa Clinical Trial for Depression
Schizophrenia - Dainippon Sumitomo Pharma Announces Lurasidone Phase III Data in Patients With Schizophrenia
Seattle Genetics, Inc. - Seattle Genetics Announces SGN-35 Clinical Data to be Presented at the American Society of Clinical Oncology Annual Meeting
Synta Pharmaceuticals Corp. - Synta Announces Elesclomol Phase 3 Melanoma Data to be Featured in Oral Presentation at the Annual Meeting of the American Society of Clinical Oncology ASCO
ZIOPHARM Oncology, Inc. - ZIOPHARM Presentations at the American Society of Clinical Oncology ASCO Annual Meeting
ZymoGenetics, Inc. - Final Phase 2 Results for IL-21 in Renal Cell Cancer Show Tolerability and Enhanced Efficacy of Nexavar Combination
